Navigation Links
Stronger EPA leadership needed to improve water quality in Mississippi River
Date:10/16/2007

WASHINGTON The U.S. Environmental Protection Agency must take a more aggressive leadership role in implementing the Clean Water Act if water quality in the Mississippi River and the northern Gulf of Mexico is to improve, says a new report from the National Research Council. EPA has failed to use its authority under the act to adequately coordinate and oversee state activities along the Mississippi and ensure progress toward the act's goal of "fishable and swimmable" waters, the report says. States along the river also must be more proactive and cooperative in their efforts to monitor and improve water quality.

In particular, greater effort is needed to ensure that the river is monitored and evaluated as a single system, said the committee that wrote the report. The 10 states along the river corridor all conduct their own programs to monitor water quality, but state resources devoted to these programs vary widely, and there is no single program that oversees the entire river, making it an "orphan" in terms of monitoring and assessment of its water quality, the report says. It recommends that EPA take the lead in coordinating these tasks along the river.

"The limited attention being given to monitoring and managing the Mississippi's water quality does not match the river's significant economic, ecological, and cultural importance," said committee chair David A. Dzombak, Blenko Professor of Environmental Engineering and director of the Steinbrenner Institute for Environmental Education and Research at Carnegie Mellon University, Pittsburgh. "In addressing water-quality problems in the river, EPA and the states should draw upon the useful experience in the Chesapeake Bay watershed, where for decades the agency has been working together with states surrounding the bay to reduce nutrient pollution and improve water quality. EPA should demonstrate similar leadership for the Mississippi River."

The report evaluates efforts to implement the
'/>"/>

Contact: Sara Frueh
news@nas.edu
202-334-2138
The National Academies
Source:Eurekalert

Page: 1 2 3 4

Related biology news :

1. Secrets of the sea yield stronger artificial bone
2. Negative effects of caffeine are stronger on daytime sleep than on nocturnal sleep
3. Natural polyester makes new sutures stronger, safer
4. A much-needed shot in the arm for HIV vaccine development
5. AIDS expert says global strategy needed to combat feminization of HIV/AIDS
6. Clear rules needed to govern deep sea bioprospecting: UNU
7. Quick identification needed to save Floridas citrus industry from devastating disease
8. Womb needed for proper brain development
9. Molecular research suggest shift needed in how some drugs are created
10. Gene needed for butterfly transformation also key for insects like grasshoppers
11. Cancer virus protein needed for successful infection
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... Wash. , Nov. 20, 2014 C-Labs ... for the Internet of Things (IoT), today announced the ... of chief operating officer. Previously a strategic advisor to ... finance, and operations. Mr. Traynor is based out of ... . He reports to Chris Muench , Chief ...
(Date:11/18/2014)... NEW YORK , Nov. 18, 2014 /PRNewswire/ ... iris-based identity authentication solutions, and MorphoTrust USA ... solutions and services, today announced a strategic partnership ... across enterprise, motor vehicle administration (MVA), airport screening ... leader in identity-related solutions, MorphoTrust serves consumers through ...
(Date:11/7/2014)... led by Dr. Debra Auguste, associate professor, biomedical ... The City College of New York, have identified ... for one of the most aggressive forms of ... have a high mortality rate owing to aggressive ... therapeutic options. However, Professor Auguste,s team, discovered the ...
Breaking Biology News(10 mins):C-Labs Names Former Microsoft and Bsquare Executive as Chief Operating Officer 2EyeLock, MorphoTrust Form Strategic Partnership to Pursue Commercial Enterprise Deployments 2EyeLock, MorphoTrust Form Strategic Partnership to Pursue Commercial Enterprise Deployments 3
... training video produced by Rafael Ortega, MD, the vice-chair ... Boston Medical Center (BMC) and professor of anesthesiology at ... is featured in this week,s New England Journal ... is the fifth BMC-produced video to appear in the ...
... After 30 years with Chip Supply, Inc., President ... Perrott served in various capacities through the ... tenure, Chip Supply grew into the largest independent die ... global provider of high reliability interconnect solutions, serving the ...
... BUFFALO, NY -- Exposure to air pollution early in life ... may alter her DNA and may be associated with premenopausal ... Buffalo have shown. The findings indicated that higher air ... increase levels of E-cadherin, a protein important to the adhesion ...
Cached Biology News:Pulse oximetry training video by BMC anesthesiologist published in NEJM 2Air pollution exposure affects chances of developing premenopausal breast cancer 2
(Date:12/17/2014)... IN (PRWEB) December 17, 2014 ... Laboratory Excellence following its most recent COLA inspection. ... by COLA, a national healthcare accreditation organization. Accreditation ... standards of quality in day-to-day operations, demonstrate continued ... pass a rigorous on-site laboratory survey. ...
(Date:12/17/2014)... , Dec. 17, 2014  United Therapeutics Corporation ... executive promotions as well as changes to Martine ... Executive Promotions United Therapeutics announced the ... and Co-Chief Executive Officer and David Zaccardelli , ... In connection with these promotions, Dr. Rothblatt,s title will ...
(Date:12/15/2014)... METTLER TOLEDO is pleased to announce that ... with PVM technology , is now available. The ... tool continuously captures high-resolution images under a wide ... prepares a report pairing the most relevant images ... This compelling blend of high resolution images and ...
(Date:12/15/2014)... BEIJING , Dec. 15, 2014  Origin Agritech Limited ... "), a technology-focused supplier of crop seeds in ... results for its fiscal year 2014 ended September 30, 2014, ... The Company will host a teleconference on January 8, ... Beijing time to discuss the results. To participate ...
Breaking Biology Technology:Xeno Diagnostics Receives 3rd Award for Laboratory Excellence 2United Therapeutics Corporation Announces Executive Promotions and CEO Compensation Change 2United Therapeutics Corporation Announces Executive Promotions and CEO Compensation Change 3United Therapeutics Corporation Announces Executive Promotions and CEO Compensation Change 4New Real-Time In Situ Probe-Based Video Microscope from METTLER TOLEDO 2Origin Agritech Limited to Announce Fiscal 2014 Annual Financial Results on January 8th, 2015 2Origin Agritech Limited to Announce Fiscal 2014 Annual Financial Results on January 8th, 2015 3
... 18 Martek Biosciences,(Nasdaq: MATK ) announced today ... patented, vegetarian form of DHA omega-3 for brain, eye,and ... vegetarian DHA,Oroweat 9 Grain Bread with life,sDHA from Bimbo ... Pacific Northwest, California, Arizona,and Nevada., "This new launch ...
... Baxter,International Inc. (NYSE: BAX ) announced today ... an additional $2 billion of the company,s,common stock to ... authorization., Baxter has less than $700 million of ... that was authorized in March,2007. Shares will be repurchased ...
... Calif., March 18 TorreyPines Therapeutics,Inc. (Nasdaq: ... Phase II study of,NGX267, a muscarinic agonist in ... syndrome., The company is conducting a randomized, ... to evaluate,the safety, tolerability and efficacy of this ...
Cached Biology Technology:Martek Announces Launch of Oroweat 9 Grain Bread, First Bread with Martek's life'sDHA 2Martek Announces Launch of Oroweat 9 Grain Bread, First Bread with Martek's life'sDHA 3Baxter's Board of Directors Approves New Share Repurchase Authorization of $2 Billion 2TorreyPines Therapeutics Initiates Phase II Study of Muscarinic Agonist NGX267 for Treatment of Xerostomia 2TorreyPines Therapeutics Initiates Phase II Study of Muscarinic Agonist NGX267 for Treatment of Xerostomia 3TorreyPines Therapeutics Initiates Phase II Study of Muscarinic Agonist NGX267 for Treatment of Xerostomia 4
Tube-O-DIALYZER Floats, small....
Nestin, Human...
Rabbit polyclonal to Survivin DEx3 ( Abpromise for all tested applications). entrezGeneID: 332 SwissProtID: O15392...
Smac/DIABLO (mouse) (CT) rabbit polyclonal antibody...
Biology Products: